40000 sale 13200 debt 22500 left -- comment in court hearing
http://ir.bindtherapeutics.com/releasedetail.cfm?ReleaseID=976156 "Collectively, these actions are expected to bring BIND's quarterly cash burn rate to approximately $6 million per quarter by the third quarter of 2016." 7m cash burn estimate for this quarter (estimated) plus let's say 800k severance
23.7m cash assets -9.56m remaining liabilities -4.7m on the cowen and other expenses -7m for operating costs -700k for severance +40m Pfizer payment -13.4m for Hercules debt
28.355m 20,886,802.00 shares outstanding $1.35 per share
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.